BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

PROSTRAKAN INC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

PROSTRAKAN INC

via ALSTON & BIRD LLP

1st Quarter (Jan 1 - Mar 31) · 2009Posted Apr 20, 2009Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: PROSTRAKAN INC
Description: Pharmaceutical Manufacturer
Location: * Undetermined

Registrant

Firm: ALSTON & BIRD LLP
Description: Law Firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
CMS coverage decision for anti-emetics.
Lobbyistsmr PETER M KAZON · TIMOTHY P TRYSLA · RUDY MISSMAR
TargetedCenters For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.